Toxic epidermal necrolysis in hemodialysis patient

Authors
Uday Venkat Mateti 1
Shankar Prasad Nagaraju 2
Manohar Bairy 2
Ravindra Prabhu Attur 2
Anantha Naik Nagappa 1
Anuradha Calicut Kini Rao 3
1 Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India
2 Department of Nephrology, Kasturba Medical College, Kasturba Hospital, Manipal University, Manipal, Karnataka, India
3 Department of Pathology, Kasturba Medical College, Kasturba Hospital, Manipal University, Manipal, Karnataka, India
Abstract
Toxic epidermal necrolysis (TEN) is a rare and life-threatening allergic drug reaction. We report a 26-year-old young female with end-stage renal disease on maintenance hemodialysis developing TEN while on filgrastim and phenytoin. It was successfully treated with intravenous immunoglobulins and steroids.

Keywords

1.
Endorf FW, Cancio LC, Gibran NS. Toxic epidermal necrolysis clinical guidelines. J Burn Care Res 2008;29:706-12.  Back to cited text no. 1
    
2.
Fernández FA, Pintor E, Quesada R, Garcés FJ. Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy. Actas Dermosifiliogr 2007;98:483-5.  Back to cited text no. 2
    
3.
Radhakrishnan K, Nayak SD, Kumar SP, Sarma PS. Profile of antiepileptic pharmacotherapy in a tertiary referral center in South India: A pharmacoepidemiologic and pharmacoeconomic study. Epilepsia 1999;40:179-85.  Back to cited text no. 3
    
4.
Mathur S, Sen S, Ramesh L, M-Kumar S. Utilization pattern of antiepileptic drugs and their adverse effects, in a teaching hospital. Asian J Pharm Clin Res 2010;3:55-9.  Back to cited text no. 4
    
5.
Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008;128:35-44.  Back to cited text no. 5
Advanced Biomedical Research
Volume 2015, February
February 2015
Pages 1-3